Series B funding round for Enveda Biosciences raising $51M in April 2023
Series B funding round for Enveda Biosciences raising $51M in April 2023
| Investor | Firm Type | Partner |
|---|
KinnevikLEAD | Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Non Profit | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Henry Kravis |
| Angel | rajiv chegu |
| Angel | Chris Gibson |
This company has completed 7 funding rounds. Current round is highlighted.
Total Raised
$592M
Top Valuation
-
Enveda Biosciences raised $51M in a Series B round.
The round was announced on 04/01/23.
The round was led by Kinnevik.